Your browser doesn't support javascript.
loading
Tumor deposits in salivary gland tumors.
Sarioglu, Sulen; Kilicarslan, Emel; Aydin, Barbaros; Kozen, Melih Arif; Akman, Fadime; Oztop, Ilhan; Ada, Emel; Ikiz, Ahmet Omer.
Afiliación
  • Sarioglu S; Department of Pathology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Kilicarslan E; Department of Pathology, Bitlis Tatvan Public Hospital, Bitlis, Turkey.
  • Aydin B; Department of Radiation Oncology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Kozen MA; Department of Otorhinolaryngology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Akman F; Department of Radiation Oncology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Oztop I; Department of Medical Oncology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Ada E; Department of Radiology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
  • Ikiz AO; Department of Otorhinolaryngology, Dokuz Eylul University School of Medicine, Izmir, Turkey.
Pathol Int ; 68(3): 183-189, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29465761
Tumor deposits (TDs), identified in different types of carcinomas are associated with poor prognosis. Salivary gland tumors were evaluated for the first time for TDs in this series. Pathological and clinical features of 25 salivary gland carcinomas primarily treated surgically including neck dissection were determined and all cases were evaluated for TDs in dissection specimens. Seven patients (28%) had TDs. There was no difference for TDs when histological type, tumor grade, tumor localization, pT, pN stage, surgical margin, lymphovascular, perineural invasion, local recurrence, distant metastatic disease and overall survival were considered. Disease-free survival rates at 12 and 24 months were 52.5%, 28.6% and 73.3%, 57.1%, for cases with and without TDs (P = 0.463). Overall survival rates at 12 and 24 months for these groups were 85.7% and 57.1 versus 86.7% and 66.7% respectively (P = 0.916). Mean estimated recurrence-free survival time for all cases, TD negative and TD positive cases were: 171.86, 182.72 and 82.42 months, respectively. Mean estimated overall survival time for these groups were 175.80, 186.489 and 89.70 months, respectively. TDs were described in salivary gland tumors for the first time in this series and seem to be associated with poor prognosis requiring further evaluation in larger series.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pathol Int Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pathol Int Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Turquía